METHODS OF USE OF ANTI-SORTILIN ANTIBODIES
The present disclosure is generally directed to the use of antibodies that specifically bind one or more epitopes within a sortilin protein, e.g., human sortilin or mammalian sortilin, for treating and/or delaying progression of a disease, disorder, or injury in an individual in need thereof. La pré...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ROSENTHAL, Arnon LIAO, Yijie WARD, Michael F PAUL, Robert YEH, Felix Leejia LONG, Hua |
| description | The present disclosure is generally directed to the use of antibodies that specifically bind one or more epitopes within a sortilin protein, e.g., human sortilin or mammalian sortilin, for treating and/or delaying progression of a disease, disorder, or injury in an individual in need thereof.
La présente divulgation concerne de manière générale l'utilisation d'anticorps qui se lient spécifiquement à un ou à plusieurs épitopes dans une protéine sortiline, par exemple la sortiline humaine ou la sortiline de mammifère, afin de traiter et/ou de retarder la progression d'une maladie, d'un trouble ou d'une lésion chez un individu le nécessitant. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022120352A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022120352A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022120352A13</originalsourceid><addsrcrecordid>eNrjZNDydQ3x8HcJVvB3UwgNdgVRjn4hnrrB_kEhnj6efmCek7-Lp2swDwNrWmJOcSovlOZmUHZzDXH20E0tyI9PLS5ITE7NSy2JD_c3MjAyMjQyMDY1cjQ0Jk4VANRbJWE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS OF USE OF ANTI-SORTILIN ANTIBODIES</title><source>esp@cenet</source><creator>ROSENTHAL, Arnon ; LIAO, Yijie ; WARD, Michael F ; PAUL, Robert ; YEH, Felix Leejia ; LONG, Hua</creator><creatorcontrib>ROSENTHAL, Arnon ; LIAO, Yijie ; WARD, Michael F ; PAUL, Robert ; YEH, Felix Leejia ; LONG, Hua</creatorcontrib><description>The present disclosure is generally directed to the use of antibodies that specifically bind one or more epitopes within a sortilin protein, e.g., human sortilin or mammalian sortilin, for treating and/or delaying progression of a disease, disorder, or injury in an individual in need thereof.
La présente divulgation concerne de manière générale l'utilisation d'anticorps qui se lient spécifiquement à un ou à plusieurs épitopes dans une protéine sortiline, par exemple la sortiline humaine ou la sortiline de mammifère, afin de traiter et/ou de retarder la progression d'une maladie, d'un trouble ou d'une lésion chez un individu le nécessitant.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220609&DB=EPODOC&CC=WO&NR=2022120352A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76292</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220609&DB=EPODOC&CC=WO&NR=2022120352A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROSENTHAL, Arnon</creatorcontrib><creatorcontrib>LIAO, Yijie</creatorcontrib><creatorcontrib>WARD, Michael F</creatorcontrib><creatorcontrib>PAUL, Robert</creatorcontrib><creatorcontrib>YEH, Felix Leejia</creatorcontrib><creatorcontrib>LONG, Hua</creatorcontrib><title>METHODS OF USE OF ANTI-SORTILIN ANTIBODIES</title><description>The present disclosure is generally directed to the use of antibodies that specifically bind one or more epitopes within a sortilin protein, e.g., human sortilin or mammalian sortilin, for treating and/or delaying progression of a disease, disorder, or injury in an individual in need thereof.
La présente divulgation concerne de manière générale l'utilisation d'anticorps qui se lient spécifiquement à un ou à plusieurs épitopes dans une protéine sortiline, par exemple la sortiline humaine ou la sortiline de mammifère, afin de traiter et/ou de retarder la progression d'une maladie, d'un trouble ou d'une lésion chez un individu le nécessitant.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDydQ3x8HcJVvB3UwgNdgVRjn4hnrrB_kEhnj6efmCek7-Lp2swDwNrWmJOcSovlOZmUHZzDXH20E0tyI9PLS5ITE7NSy2JD_c3MjAyMjQyMDY1cjQ0Jk4VANRbJWE</recordid><startdate>20220609</startdate><enddate>20220609</enddate><creator>ROSENTHAL, Arnon</creator><creator>LIAO, Yijie</creator><creator>WARD, Michael F</creator><creator>PAUL, Robert</creator><creator>YEH, Felix Leejia</creator><creator>LONG, Hua</creator><scope>EVB</scope></search><sort><creationdate>20220609</creationdate><title>METHODS OF USE OF ANTI-SORTILIN ANTIBODIES</title><author>ROSENTHAL, Arnon ; LIAO, Yijie ; WARD, Michael F ; PAUL, Robert ; YEH, Felix Leejia ; LONG, Hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022120352A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ROSENTHAL, Arnon</creatorcontrib><creatorcontrib>LIAO, Yijie</creatorcontrib><creatorcontrib>WARD, Michael F</creatorcontrib><creatorcontrib>PAUL, Robert</creatorcontrib><creatorcontrib>YEH, Felix Leejia</creatorcontrib><creatorcontrib>LONG, Hua</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROSENTHAL, Arnon</au><au>LIAO, Yijie</au><au>WARD, Michael F</au><au>PAUL, Robert</au><au>YEH, Felix Leejia</au><au>LONG, Hua</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS OF USE OF ANTI-SORTILIN ANTIBODIES</title><date>2022-06-09</date><risdate>2022</risdate><abstract>The present disclosure is generally directed to the use of antibodies that specifically bind one or more epitopes within a sortilin protein, e.g., human sortilin or mammalian sortilin, for treating and/or delaying progression of a disease, disorder, or injury in an individual in need thereof.
La présente divulgation concerne de manière générale l'utilisation d'anticorps qui se lient spécifiquement à un ou à plusieurs épitopes dans une protéine sortiline, par exemple la sortiline humaine ou la sortiline de mammifère, afin de traiter et/ou de retarder la progression d'une maladie, d'un trouble ou d'une lésion chez un individu le nécessitant.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2022120352A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | METHODS OF USE OF ANTI-SORTILIN ANTIBODIES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T09%3A33%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROSENTHAL,%20Arnon&rft.date=2022-06-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022120352A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |